Dopamine transporter and D2-receptor density in late-onset alcoholism
- PMID: 10639691
- DOI: 10.1007/s002130051173
Dopamine transporter and D2-receptor density in late-onset alcoholism
Abstract
Rationale: Late onset type 1 alcoholism has been suggested to be associated with an underlying dopaminergic defect. Therefore, it is relevant to study both postsynaptic D2-receptor and presynaptic dopamine transporter (DAT) densities among alcoholics.
Objective: We investigated DAT densities, along with striatal and extrastriatal dopamine D2-receptor densities, in nine nonviolent late-onset male alcoholics, who had no major mental disorder nor antisocial personality disorder (ASPD), and nine healthy controls.
Methods: [123I]PE2I and [123I]epidepride were used in SPECT imaging.
Results: DAT occupancy ratios (striatum/cerebellum) were significantly lower among alcoholics than in controls. Extrastriatal D2-receptor occupancy ratios (temporal pole/cerebellum) were not significantly different between the groups.
Conclusions: Striatal presynaptic DAT densities are decreased among type 1 alcoholics, and this finding is not associated with recent alcohol abuse.
Similar articles
-
Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics.Nat Med. 1995 Jul;1(7):654-7. doi: 10.1038/nm0795-654. Nat Med. 1995. PMID: 7585146
-
Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients.Neurosci Lett. 2000 Sep 29;292(1):57-9. doi: 10.1016/s0304-3940(00)01423-3. Neurosci Lett. 2000. PMID: 10996449
-
Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics.Mol Psychiatry. 2001 May;6(3):261-7. doi: 10.1038/sj.mp.4000859. Mol Psychiatry. 2001. PMID: 11326293
-
Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy.Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1631-8. doi: 10.1007/s00259-004-1578-x. Epub 2004 Jul 22. Eur J Nucl Med Mol Imaging. 2004. PMID: 15583914 Clinical Trial.
-
Evaluation of the superselective radioligand [123I]PE2I for imaging of the dopamine transporter in SPECT.Dan Med Bull. 2011 May;58(5):B4279. Dan Med Bull. 2011. PMID: 21535991 Review.
Cited by
-
Mapping dopaminergic projections in the human brain with resting-state fMRI.Elife. 2022 Feb 3;11:e71846. doi: 10.7554/eLife.71846. Elife. 2022. PMID: 35113016 Free PMC article.
-
Alcohol and the Brain.Nutrients. 2021 Nov 4;13(11):3938. doi: 10.3390/nu13113938. Nutrients. 2021. PMID: 34836193 Free PMC article. Review.
-
Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.Neuropsychopharmacology. 2019 Mar;44(4):660-667. doi: 10.1038/s41386-018-0191-9. Epub 2018 Aug 27. Neuropsychopharmacology. 2019. PMID: 30188512 Free PMC article.
-
Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease.Brain Behav. 2018 Jul;8(7):e01008. doi: 10.1002/brb3.1008. Epub 2018 Jun 1. Brain Behav. 2018. PMID: 29856137 Free PMC article.
-
Perspectives on fronto-fugal circuitry from human imaging of alcohol use disorders.Neuropharmacology. 2017 Aug 1;122:189-200. doi: 10.1016/j.neuropharm.2017.01.018. Epub 2017 Jan 22. Neuropharmacology. 2017. PMID: 28118989 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical